VISFO
Knowledge base
Key Clinical Investigators (KCIs)
Elevate your clinical trial strategy by identifying and engaging with the most impactful investigators in your therapy area.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Proven clinical experience and expertise
Criteria 2
Affiliated with a leading healthcare or academic research institute
Criteria 3
Demonstrates a strong track record of patient enrollment and retention in clinical trials
Criteria 4
Demonstrates a strong track record of completing clinical trials
Criteria 5
Demonstrates a strong publication record in peer-reviewed journals
Criteria 6
Actively participates in professional organizations and conferences
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
Interrogate integrated and enriched data from diverse sources to identify KCIs in your therapy area and markets of interest.
Analyze
Confidently inform your engagement strategy by using sophisticated data analytics tools to:
Reveal KCI publication histories
- Develop a holistic understanding of each KCI’s expertise using up-to-date bibliometrics alongside a relevant literature library for each individual.
Understand individual KCI impact
- Determine who the top KCIs are in your therapy area by leveraging our proprietary KCI impact factors based on a combination of:
- the number of clinical trials in which they have participated
- the percent of trials in which they were the principal investigator
- the percent of trials they were able to over-recruit for
- the number of trials they helped successfully run to completion.
Map KCI geolocation and professional networks
- Find the top investigators close to your planned clinical trial sites by mapping KCIs and their networks (at institute, city, state, country and global level).
Maintain a clear view of the KCI landscape throughout the lifecycle of your product with user-defined data updates.
Global systemic lupus erythematosus (SLE) trial site activity
Use cases
How can this help your team...
Medical Affairs
Work with key investigators to plan and execute your publication strategies
Collaborate with investigators to develop and deliver credible medical education programs
Leverage KCI expertise to inform your internal training programs, ensuring your Medical Affairs teams are well-versed in the clinical benefits and real-world applications of your new therapy
Market Access
Leverage KCI endorsement to enhance the credibility of data presented to payers and Health Technology Assessment (HTA) bodies
Build relationships with KCIs willing to act as advocates for your new therapy, influencing other key stakeholders
Understand KCI perspectives on the clinical and economic value of your new therapy
Clinical Development
Identify investigators to help you conduct successful trials and guide data analysis
Bring credibility to your clinical trials by working with KCIs with established reputations and professional standing
Work with KCIs to increase enrollment efficiency and maintain participant engagement
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
